RESUMEN
Proinflammatory IL-17 plays an important role in various diseases and defence against extracellular microorganisms. Healing of leishmaniasis is promoted by Th1/Tc1 cells, whereas Th2/Treg are associated with worsened disease outcome. In addition, high expression of IL-17A in Leishmania-susceptible BALB/c and artificial overexpression of IL-17A in T cells in resistant C57BL/6 mice worsened disease outcome. Since C57BL/6 mice lacking only IL-17A exhibited no phenotype, and IL-17A and IL-17F share similar receptors, but differentially regulate chemokine secretion, we studied mice lacking both IL-17A and IL-17F (IL-17A/F-/- ) in infections with Leishmania major. Interestingly, lesion volumes and parasite burdens were comparable to controls, IL-17A/F-/- mice developed a Th1/Tc1 phenotype, and exhibited normal lesion resolution. Thus, in C57BL/6 mice, secretion of IL-17A and IL-17F does not influence disease progression. It appears that-depending on the genetic background-cytokines of the IL-17 family might be responsible for disease progression primarily in susceptible mice.
Asunto(s)
Interleucina-17/inmunología , Leishmaniasis/inmunología , Células TH1/parasitología , Células Th2/parasitología , Animales , Linfocitos T CD4-Positivos/citología , Linfocitos T CD4-Positivos/parasitología , Cruzamientos Genéticos , Citocinas/metabolismo , Progresión de la Enfermedad , Femenino , Linfocitos Intraepiteliales/citología , Linfocitos Intraepiteliales/parasitología , Leishmania/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Fenotipo , Células TH1/citología , Células Th2/citologíaRESUMEN
Humanized mice represent a suitable preclinical test system for example therapeutic interventions in various disease settings, including infections. Here, we intended to establish such system for cutaneous leishmaniasis by infecting T, B and NK cell-deficient mice adoptively transferred with human peripheral blood mononuclear cells (PBMC). L major infection led to the establishment of parasite lesions harbouring viable parasites and human T cells, but parasite elimination was not seen due to a species-specific activity of T cell-derived human IFNγ. In addition, up to 50% of infected mice succumbed to severe graft-versus-host disease. In summary, even though long-term disease outcome assessments are impossible, this model of humanized mice can be used for studying lesion development and generation of oligoclonal anti-parasite human T cell responses in vivo.
Asunto(s)
Traslado Adoptivo , Leishmaniasis Cutánea/terapia , Leucocitos Mononucleares/trasplante , Subgrupos de Linfocitos T/trasplante , Traslado Adoptivo/efectos adversos , Animales , Progresión de la Enfermedad , Enfermedad Injerto contra Huésped/etiología , Xenoinjertos , Humanos , Interferón gamma/farmacología , Leishmaniasis Cutánea/parasitología , Macrófagos/efectos de los fármacos , Macrófagos/parasitología , Ratones , Modelos Animales , Especificidad de la Especie , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Healing of leishmaniasis-a parasitic skin disease-is associated with high levels of secreted interferon (IFN)γ and IL-12 in resistant C57BL/6 mice and humans. Susceptible BALB/c mice predominantly react with a Th17/Th2/Treg-related immune response and finally succumb to infection. Previously, we showed that BALB/c IL-17A-/- mice are protected against Leishmania (L.) major infections, indicating that IL-17A-predominantly produced by Th17 cells-plays an important role for disease outcome. We now investigated DC-derived cytokines and finally identified IL-23p19 as key cytokine responsible for induction of Leishmania-specific Th17 cells that play an important role for progressive disease in susceptible BALB/c mice.
Asunto(s)
Subunidad p19 de la Interleucina-23/genética , Leishmaniasis Cutánea/inmunología , Células Th17/citología , Animales , Citocinas/metabolismo , Células Dendríticas/metabolismo , Progresión de la Enfermedad , Interferón gamma/metabolismo , Leishmania major , Ratones , Ratones Endogámicos BALB C , Reacción en Cadena de la Polimerasa , Células Th17/inmunologíaRESUMEN
Gender-associated differences in the outcome of infections are well known. Apart from behavior-released differences in their incidence, immunological factors also contribute to disease outcome. The underlying mechanisms are often unknown. Here, we show that in murine experimental leishmaniasis, female mice develop larger skin lesions that harbor significantly more parasites, exhibit increased parasite dissemination to visceral organs associated with a shift towards T helper (Th) 2 immunity with increased levels of IL-4. Antigen presenting cells (APC) responsible for T cell priming, such as macrophages or dendritic cells, were not involved in the process. Additionally, in adoptive transfer experiments, we show that differences in the lymphoid lineage are also not critical for mediating these gender-dependent effects. In summary, neither myeloid nor lymphoid cells contribute to disease outcome against this important human pathogen, but stromal cells influenced by e.g. hormonal effects in addition to other parts of the immune system might play a role.
Asunto(s)
Hormonas/metabolismo , Leishmaniasis Cutánea/inmunología , Sexo , Células del Estroma/inmunología , Células Th2/inmunología , Animales , Diferenciación Celular , Linaje de la Célula , Células Cultivadas , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Susceptibilidad a Enfermedades , Femenino , Humanos , Interleucina-4/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Células Mieloides/inmunología , Células Mieloides/parasitología , Células del Estroma/parasitología , Balance Th1 - Th2 , Células Th2/parasitologíaRESUMEN
Jak inhibitors are increasingly used in dermatology. Despite broad inhibitory effects on cytokine signaling cascades, they only modestly increase the risk for infectious diseases. To address the molecular mechanisms underlying this unexpected clinical observation, we investigated how tofacintib (tofa), a first-in-class Jak inhibitor, regulates host defense responses in toll-like receptor 4-activated human macrophages. Specifically, we asked whether tofa inhibits anti-inflammatory IL-10 signaling, thereby counteracting the downregulation of inflammatory, host-protective pathways. We found that tofa blocked macrophage responses to IL-10 at the level of signal transducer and activator of transcription 3 phosphorylation. Furthermore, toll-like receptor 4-induced, autocrine/paracrine IL-10/IL-10R activation promoted the expression of hepcidin, the master regulator of iron metabolism, resulting in intracellular iron sequestration. In contrast, autocrine/paracrine IL-10/IL-10R activation repressed the expression of cathelicidin antimicrobial peptide as well as antigen-presenting molecules, thus together, inducing a pathogen-favoring environment. Although tofa further repressed cathelicidin, it prevented the induction of intracellular HAMP and restored the expression of antigen-presentation molecules in toll-like receptor 4-activated macrophages. Our study supports the concept that induction of IL-10/IL-10R signaling drives a complex immune evasion strategy of intracellular microbes. Moreover, we conclude that tofa has diverging effects on macrophage host response pathways, and we identify the toll-like receptor 4-IL-10-signal transducer and activator of transcription 3-HAMP axis as a potential therapeutic target to counteract immune evasion.
Asunto(s)
Inhibidores de las Cinasas Janus , Receptor Toll-Like 4 , Humanos , Interleucina-10/metabolismo , Hierro/metabolismo , Inhibidores de las Cinasas Janus/farmacología , Macrófagos/metabolismo , Piperidinas , Pirimidinas , Factor de Transcripción STAT3/metabolismo , Receptor Toll-Like 4/metabolismoAsunto(s)
Susceptibilidad a Enfermedades/inmunología , Leishmania major/inmunología , Leishmaniasis Cutánea/inmunología , Mastocitos/inmunología , Animales , Modelos Animales de Enfermedad , Humanos , Leishmaniasis Cutánea/parasitología , Mastocitos/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Infiltración Neutrófila , Proteínas Proto-Oncogénicas c-kit/genética , Proteínas Proto-Oncogénicas c-kit/metabolismo , Células Th17/microbiologíaAsunto(s)
Células de Langerhans/inmunología , Leishmania major/inmunología , Leishmaniasis Cutánea/inmunología , Linfocitos T Reguladores/inmunología , Animales , Antígenos de Superficie/metabolismo , Modelos Animales de Enfermedad , Humanos , Células de Langerhans/metabolismo , Lectinas Tipo C/metabolismo , Leishmaniasis Cutánea/parasitología , Leishmaniasis Cutánea/patología , Recuento de Linfocitos , Lectinas de Unión a Manosa/metabolismo , Ratones , Ratones Endogámicos BALB C , Piel/citología , Piel/inmunología , Piel/parasitología , Piel/patología , Organismos Libres de Patógenos EspecíficosRESUMEN
T cells can be found in skin under steady-state conditions as well as in inflammatory processes. T cells in skin play an important role in immune homeostasis as well as control of infectious, inflammatory diseases or tumors. In addition, several important and frequent skin diseases such as psoriasis, atopic dermatitis, autoimmune disease, and contact allergy are initiated by T cells. In skin diseases, the majority of antigen-specific T cells can be found in the tissue, not the peripheral blood. Here, we present a protocol suitable for isolation of skin-resident (inflammatory) T cells that can be used for an in-depth characterization of their frequency, function, and role for the respective inflammatory condition.
Asunto(s)
Piel/citología , Piel/inmunología , Linfocitos T/citología , Animales , Separación Celular/métodos , Dermatitis/inmunología , Dermatitis/patología , Humanos , Inflamación/inmunología , Inflamación/patología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Linfocitos T/patologíaRESUMEN
Leishmaniasis is a parasitic infection affecting â¼12 million people worldwide, mostly in developing countries. Treatment options are limited and no effective vaccines exist to date. Natural Killer T (NKT) cells are a conserved innate-like lymphocyte population with immunomodulating effects in various settings. A number of reports state a role of NKT cells in different models of Leishmania infection. Here, we investigated the effect of NKT cells in a physiologically relevant, intradermal low dose infection model. After inoculation of 103 infectious-stage L. major, comparable numbers of skin-immigrating NKT cells in both susceptible BALB/c mice and resistant C57BL/6 mice were noted. Compared to their wild type counterparts, NKT cell-deficient mice on a C57BL/6 background were better able to contain infection with L. major and showed decreased IL-4 production in cytokine analysis performed 5 and 8 weeks after infection. Low doses of the NKT cell stimulating αGalCer analog PBS57 applied at the time of infection led to disease exacerbation in C57BL/6 wild-type, but not NKT-deficient mice. The effect was dependent both on the timing and amount of PBS57 administered. The effect of NKT cell stimulation by PBS57 proved to be IL-4 dependent, as it was neutralized in IL-4-deficient C57BL/6 or anti-IL-4 antibody-treated wild-type mice. In contrast to C57BL/6 mice, administration of PBS57 in susceptible BALB/c mice resulted in an improved course of disease. Our results reveal a strain- and cytokine-dependent regulatory role of NKT cells in the development of immunity to low dose L. major infections. These effects, probably masked in previous studies using higher parasite inocula, should be considered in future therapy and immunization approaches.